Many trial supply disruptions are set in motion years before enrollment begins. Hedley Rees explains how early decisions shape risk, forecasting, inventory, and execution.
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
- How The Iran Conflict Threatens Global Clinical Supply Chains
- Optimizing CMO/CRO Partnerships To Improve Clinical Trial Supply Performance
- Unlocking The Value Of Real-World Data In Global Clinical Trials
- Clinical Supply Chain Continuity And Resilience
- Mastering Temperature Control And Advanced Therapy Logistics In Global Clinical Supply Chains
- How AI Can Solve Poor Communication Across Clinical Trial Supply Chains
- Invisible Yet Accountable: How Clinical Supply Pressures Build Strategic Leaders
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Treating Deficiencies In Employee Training And Mentorship
Investing in employee training and development is not just beneficial for the employees. It also contributes significantly to the organization’s success and competitive advantage.
-
Bespoke RTSM Systems Empower Precision Medicine
Randomization & trial supply management (RTSM) are critical functions of clinical trial IRT systems, supporting patient randomization plus managing drug inventory, site resupply, and participant dispensation.
-
Improving Site Efficiency With Automated Drug Resupply And Forecasting
Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.
-
Benefits Of Electronic Labels: Investigational Medicinal Products
When a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.
-
Effective Use Of IRT In Decentralized And Hybrid Clinical Trials
Uncover the ways interactive response technologies are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.
-
Key Considerations For Emerging Companies When Selecting Packaging Components
Recognizing the importance of packaging development and prioritizing its role in drug development early on can help proactively identify potential delays and overcome risks.
-
Managing Clinical Trial Supply Challenges In Complex Studies
Complex studies require flexible supply strategies that can adjust to shifting timelines, varied modalities, and global site needs. Adaptive, scalable planning helps lower risk.
-
Building Robust Clinical Supply Chains To Support Global Trials
Ensuring drugs reach patients at the right time and place is crucial. Review key areas to consider as you build a robust clinical supply chain that supports global trials effectively and efficiently.
-
Why RTSM Software Doesn't Belong Inside An All-In-One Suite
Don’t let administrative convenience compromise study integrity. Discover why purpose-built RTSM is essential for managing the technical complexities and specialized demands of modern trials.
-
Outgrowing Excel: Implementing RTSM In A Live Phase I Trial
Learn how a clinical-stage oncology biotech successfully transitioned a live Phase I trial from manual spreadsheets to RTSM without disrupting site momentum or patient enrollment.
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
- From Invisible to Integral: Inviting Clinical Supply Expertise to the Planning Table
- Invisible Yet Accountable: How Clinical Supply Pressures Build Strategic Leaders
- Decision Authority And Direction — The Gap In Deviation Planning
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.